Detection of mixed clarithromycin-resistant and -susceptible Helicobacter pylori using nested PCR and direct sequencing of DNA extracted from faeces

Journal of Medical Microbiology

Volumn 56, Issue 9, 2007, Pages 1174-1180

  Noguchi, Norihisa ^a   Rimbara, Emiko ^a   Kato, Ayami ^a   Tanaka, Akifumi ^b   Tokunaga, Kengo ^b   Kawai, Takashi ^c   Takahashi, Shin'ichi ^b   Sasatsu, Masanori ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^b KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; BACTERIAL DNA; CLARITHROMYCIN; GUANINE; RIBOSOME RNA; RNA 23S;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM ISOLATE; DIAGNOSTIC ACCURACY; DNA EXTRACTION; DNA SEQUENCE; FECES; FEMALE; GENE MUTATION; HELICOBACTER PYLORI; HUMAN; JAPAN; MALE; MIXED INFECTION; MUTATIONAL ANALYSIS; NESTED POLYMERASE CHAIN REACTION; NON INVASIVE MEASUREMENT; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA GENE; SEQUENCE ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; DNA, BACTERIAL; DNA, RIBOSOMAL; DRUG RESISTANCE, BACTERIAL; FECES; FEMALE; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; POINT MUTATION; POLYMERASE CHAIN REACTION; RNA, RIBOSOMAL, 23S; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA;

EID: 34748863525     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.47302-0     Document Type: Article

References (36)

1. Akiyama, H., Watanabe, T., Wakabayashi, K., Nakade, S., Yasui, S., Sakata, K., Chiba, R., Spiegelhalter, F., Hino, A. & Maitani, T. (2005). Quantitative detection system for maize sample containing combined-trait genetically modified maize. Anal Chem 77, 7421-7428.
2. Alarcon, T., Vega, A. E., Domingo, D., Martinez, M. J. & Lopez-Brea, M. (2003). Clarithromycin resistance among Helicobacter pylori strains isolated from children: prevalence and study of mechanism of resistance by PCR-restriction fragment length polymorphism analysis. J Clin Microbiol 41, 486-499.
3. Asaka, M., Satoh, K., Sugano, K., Sugiyama, T., Takahashi, S., Fukuda, Y., Ota, H., Murakami, K., Kimura, K. & Shimoyama, T. (2001). Guidelines in the management of Helicobacter pylori infection in Japan. Helicobacter 6, 177-186.
4. Booka, M., Okuda, M., Shin, K., Miyashiro, E., Hayashi, H., Yamauchi, K., Tamura, Y. & Yoshikawa, N. (2005). Polymerase chain reaction-restriction fragment length polymorphism analysis of clarithromycin-resistant Helicobacter pylori infection in children using stool sample. Helicobacter 10, 205-213.
5. CLSI (2002). Performance Standards for Antimicrobial Susceptibility Testing: Twelfth Informational Supplement. Wayne, PA: Clinical and Laboratory Standards Institute.
6. Fontana, C., Favaro, M., Minelli, S., Criscuolo, A. A., Pietroiusti, A., Galante, A. & Favalli, C. (2002). New site of modification of 23S rRNA associated with clarithromycin resistance of Helicobacter pylori clinical isolates. Antimicrob Agents Chemother 46, 3765-3769.
7. Fontana, C., Favaro, M., Pietroiusti, A., Pistoia, E. S., Galante, A. & Favalli, C. (2003). Detection of clarithromycin-resistant Helicobacter pylori in stool samples. J Clin Microbiol 41, 3636-3640.
8. Furuta, T., Shirai, N., Takashima, M., Xiao, F., Hanai, H., Sugimura, H., Ohashi, K., Ishizaki, T. & Kaneko, E. (2001). Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin. Clin Pharmacol Ther 69, 158-168.
9. Goodwin, C. S., Blincow, E. D., Warren, J. R., Waters, T. E., Sanderson, C. R. & Easton, L. (1985). Evaluation of cultural techniques for isolating Campylobacter pyloridis from endoscopic biopsies of gastric mucosa. J Clin Pathol 38, 1127-1131.
10. 13C-urea breath test. Lancet i, 1174-1177.
11. Hoshiya, S., Watanabe, K., Tokunaga, K., Tanaka, A., Ninomiya, H., Shingaki, M., Itoh, T., Saito, S., Ishida, H. & Takahashi, S. (2000). Relationship between eradication therapy and clarithromycin-resistant Helicobacter pylori in Japan. J Gastroenterol 35, 10-14.
12. Ito, M., Tanaka, S., Kim, S., Tahara, K., Kawamura, Y., Sumii, M., Takehara, Y., Hayashi, K., Okamoto, E. & other authors (2005). A combination of the Helicobacter pylori stool antigen test and urea breath test is useful for clinical evaluation of eradication therapy: a multicenter study. J Gastroenterol Hepatol 20, 1241-1245.
13. Kato, M., Yamaoka, Y., Kim, J. J., Reddy, R., Asaka, M., Kashima, K., Osato, M. S., El-Zaatari, F. A., Graham, D. Y. & Kwon, D. H. (2000). Regional differences in metronidazole resistance and increasing clarithromycin resistance among Helicobacter pylori isolates from Japan. Antimicrob Agents Chemother 44, 2214-2216.
14. Khan, R., Nahar, S., Sultana, J., Ahmad, M. M. & Rahman, M. (2004). T2182C mutation in 23S rRNA is associated with clarithromycin resistance in Helicobacter pylori isolates obtained in Bangladesh. Antimicrob Agents Chemother 48, 3567-3569.
15. Kim, J. M., Kim, J. S., Kim, N., Kim, S. G., Jung, H. C. & Song, I. S. (2006). Comparison of primary and secondary antimicrobial minimum inhibitory concentrations for Helicobacter pylori isolated from Korean patients. Int J Antimicrob Agents 28, 6-13.
16. Kuipers, E. J. (1997). Helicobacter pylori and the risk and management of associated diseases: gastritis, ulcer disease, atrophic gastritis and gastric cancer. Aliment Pharmacol Ther 11 (Suppl. 1), 71-88.
17. Kusters, J. G., Gerrits, M. M., Van Strijp, J. A. & Vandenbroucke-Grauls, C. M. (1997). Coccoid forms of Helicobacter pylori are the morphologic manifestation of cell death. Infect Immun 65, 3672-3679.
18. Kusters, J. G., van Vliet, A. H. & Kuipers, E. J. (2006). Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev 19, 449-490.
19. Leodolter, A., Vaira, D., Bazzoli, F., Schutze, K., Hirschl, A., Megraud, F. & Malfertheiner, P. (2003). European multicentre validation trial of two new non-invasive tests for the detection of Helicobacter pylori antibodies: urine-based ELISA and rapid urine test. Aliment Pharmacol Ther 18, 927-931.
20. Leong, R. W. & Sung, J. J. (2002). Helicobacter species and hepatobiliary diseases. Aliment Pharmacol Ther 16, 1037-1045.
21. Malfertheiner, P., Megraud, F., O'Morain, C., Hungin, A. P., Jones, R., Axon, A., Graham, D. Y. & Tytgat, G. (2002). Current concepts in the management of Helicobacter pylori infection - the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 16, 167-180.
22. Matsuki, T., Watanabe, K., Fujimoto, J., Kado, Y., Takada, T., Matsumoto, K. & Tanaka, R. (2004). Quantitative PCR with 16S rRNA-gene-targeted species-specific primers for analysis of human intestinal bifidobacteria. Appl Environ Microbiol 70, 167-173.
23. McOrist, A. L., Jackson, M. & Bird, A. R. (2002). A comparison of five methods for extraction of bacterial DNA from human faecal samples. J Microbiol Methods 50, 131-139.
24. Monteiro, L., Gras, N., Vidal, R., Cabrita, J. & Megraud, F. (2001). Detection of Helicobacter pylori DNA in human feces by PCR: DNA stability and removal of inhibitors. J Microbiol Methods 45, 89-94.
25. Morris, J. M., Reasonover, A. L., Bruce, M. G., Bruden, D. L., McMahon, B. J., Sacco, F. D., Berg, D. E. & Parkinson, A. J. (2005). Evaluation of seaFAST, a rapid fluorescent in situ hybridization test, for detection of Helicobacter pylori and resistance to clarithromycin in paraffin-embedded biopsy sections. J Clin Microbiol 43, 3494-3496.
26. Nurgalieva, Z. Z., Opekun, A. R. & Graham, D. Y. (2006). Problem of distinguishing false-positive tests from acute or transient Helicobacter pylori infections. Helicobacter 11, 69-74.
27. Prokhorenko, I. A., Malakhov, A. D., Kozlova, A. A., Momynaliev, K., Govorun, V. M. & Korshun, V. A. (2006). Phenylethynylpyrene-labeled oligonucleotide probes for excimer fluorescence SNP analysis of 23S rRNA gene in clarithromycin-resistant Helicobacter pylori strains. Mutat Res 599, 144-151.
28. Rimbara, E., Noguchi, N., Tanabe, M., Kawai, T., Matsumoto, Y. & Sasatsu, M. (2005a). Susceptibilities to clarithromycin, amoxycillin and metronidazole of Helicobacter pylori isolates from the antrum and corpus in Tokyo, Japan, 1995-2001. Clin Microbiol Infect 11, 307-311.
29. Rimbara, E., Noguchi, N., Yamaguchi, T., Narui, K., Kawai, T. & Sasatsu, M. (2005b). Development of a highly sensitive method for detection of clarithromycin-resistant Helicobacter pylori from human feces. Curr Microbiol 51, 1-5.
30. Schabereiter-Gurtner, C., Hirschl, A. M., Dragosics, B., Hufnagl, P., Puz, S., Kovach, Z., Rotter, M. & Makristathis, A. (2004). Novel real-time PCR assay for detection of Helicobacter pylori infection and simultaneous clarithromycin susceptibility testing of stool and biopsy specimens. J Clin Microbiol 42, 4512-4518.
31. Shuber, A. P., Ascano, J. J., Boynton, K. A., Mitchell, A., Frierson, H. F., Jr, El-Rifai, W. & Powell, S. M. (2002). Accurate, noninvasive detection of Helicobacter pylori DNA from stool samples: potential usefulness for monitoring treatment. J Clin Microbiol 40, 262-264.
32. Thomas, J. E., Gibson, G. R., Darboe, M. K., Dale, A. & Weaver, L. T. (1992). Isolation of Helicobacter pylori from human faeces. Lancet 340, 1194-1195.
33. Toracchio, S., Aceto, G. M., Mariani-Costantini, R., Battista, P. & Marzio, L. (2004). Identification of a novel mutation affecting domain V of the 23S rRNA gene in Helicobacter pylori. Helicobacter 9, 396-399.
34. Vaira, D., Malfertheiner, P., Megraud, F., Axon, A. T., Deltenre, M., Hirschl, A. M., Gasbarrini, G., O'Morain, C., Garcia, J. M. & other authors (1999). Diagnosis of Helicobacter pylori infection with a new non-invasive antigen-based assay. HpSA European study group. Lancet 354, 30-33.
35. van Doom, L. J., Glupczynski, Y., Kusters, J. G., Mégraud, F., Midolo, P., Maggi-Solcà, N., Queiroz, D. M., Nouhan, N., Stet E. & Quint W. G. (2001). Accurate prediction of macrolide resistance in Helicobacter pylori by a PCR line probe assay for detection of mutations in the 23S rRNA gene: multicenter validation study. Antimicrob Agents Chemother 45, 1500-1504.
36. Wong, B. C., Wang, W. H., Berg, D. E., Fung, F. M., Wong, K. W., Wong, W. M., Lai, K. C., Cho, C. H., Hui, W. M. & Lam, S. K. (2001). High prevalence of mixed infections by Helicobacter pylori in Hong Kong: metronidazole sensitivity and overall genotype. Aliment Pharmacol Ther 15, 493-503.